Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Long Hill Capital (长岭资本) is a venture capital firm established in 2016 and headquartered in Shanghai, China. The firm was founded by a team that previously led the China investing practice at New Enterprise Associates (NEA), one of the world's largest venture capital firms. Long Hill Capital focuses on technology-driven innovations in the healthcare and longevity sectors, leveraging China's demographic trends to identify promising investment opportunities.
As of 2021, Long Hill Capital manages approximately $830 million in assets under management (AUM) across six funds. The firm has a strong reputation in the market, having successfully deployed over $150 million across 34 healthcare and longevity startups in just 18 months during its Fund III period. Notable milestones include the IPO of portfolio company Hygeia Healthcare, which became the fifth largest publicly listed healthcare services company in China by market value.
Long Hill Capital primarily invests in startups within the healthcare and longevity sectors, emphasizing technology-enabled solutions that address the needs of an aging population in China. The firm adopts a thesis-driven approach, focusing on digital health, healthcare services, and healthtech, while avoiding traditional biotech or pharmaceutical investments. This strategy aligns with the demographic shift in China, where the population of seniors is expected to reach 400 million.
The firm seeks to partner with founders who are innovating at the intersection of technology and healthcare services. Long Hill Capital prefers early-stage investments but also considers select growth-stage opportunities. The firm provides operational support and strategic guidance to help its portfolio companies scale effectively in the competitive Chinese market.
Long Hill Capital has built a diverse portfolio of 34 companies, focusing on healthcare and longevity. Notable portfolio companies include:
Xiaodong Jiang: Managing Partner; previously led NEA's China investing practice from 2005 to 2015, bringing extensive experience in venture capital and healthcare investments.
Bo Jiang: Co-founder; also part of the NEA China team, contributing to the firm's deep sector expertise and investment strategy.
To pitch Long Hill Capital, startups should use the firm's website at www.lhcap.cn. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and technology aspects. Response times may vary, but founders should expect a thorough review process.
In June 2020, Long Hill Capital celebrated the IPO of portfolio company Hygeia Healthcare (6078.HK), marking a significant milestone as it became the fifth largest publicly listed healthcare services company in China. The firm has also been active in deploying over $150 million across 34 healthcare and longevity startups in the 18 months following the announcement of Fund III in April 2021.
Q?
What are Long Hill Capital's investment criteria?
A: Long Hill Capital focuses on technology-driven innovations in healthcare and longevity sectors, targeting early to growth-stage companies that address the needs of an aging population in China.
Q?
How can startups apply or pitch to Long Hill Capital?
A: Startups can pitch through the firm's website at www.lhcap.cn. It is advisable to include a detailed business plan and highlight the technology-driven aspects of the solution.
Q?
What makes Long Hill Capital different from other VC firms?
A: Long Hill Capital emphasizes a thesis-driven approach, focusing exclusively on technology-enabled transformation in healthcare and longevity sectors, rather than generalist investing.
Q?
What is the geographic scope of Long Hill Capital's investments?
A: The firm primarily invests in startups based in China, particularly those addressing the healthcare needs of the aging population.
Q?
What is the typical check size for investments?
A: Specific check size ranges are not publicly disclosed, but the firm has invested over $150 million across 34 companies in its recent fund deployment.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.